"THE KOL MEETING FOR KOL'S"
DAVIS, Calif., June 6, 2022 /CNW/ -- ELEVAI LABS, INC., ("ELEVAI" or the "Company") a science-based, data-driven regenerative aesthetic skincare company is pleased to announce that Co-Founder and CEO Dr. Jordan Plews has been selected to speak at the world-renowned Beauty Through Sciences Symposium as a Stem Cell Exosome Key Opinion Leader (KOL).
The BTS Congress (Beauty Through Science) is one of the largest aesthetic medicine symposiums in Northern Europe. The Beauty Through Science 2022 Congress is held June 2-5 in Stockholm. BTS is a boutique meeting, containing both a live show and an on-demand platform. There will be a prestigious group of KOL speakers from all over the world in a dual-track program featuring a surgical and a non-surgical track. For more information and sign up visit: https://www.beautythroughscience.com/bts-stockholm-home
Dr. Jordan Plews stated: "Stem Cell Exosome Research and technology innovation has been a passion and my life's work. I'm honored to be invited to speak at this year's BTS Congress on the science and the opportunity of topical stem cell exosomes and regenerative skin care applications. I look forward to meeting and speaking with many other talented scientists and medical aesthetic KOLs"
ELEVAI LABS, INC. is a medical aesthetic biotechnology company developing cutting-edge regenerative skin care applications. The company solves the unmet needs in the regenerative aesthetics space through a combination of cutting-edge science and next-generation consumer applications. Elevai Labs develops state-of-the-art topical aesthetic and medical-grade skincare for the physician-dispensed market, with a focus on leveraging stem cell exosome technology. Learn more about Elevai Labs at www.elevaiskincare.com.
For further information: Kendra Ciardiello, Associate Director, [email protected], 1-866-794-4940 CO: ELEVAI Labs Inc.
SOURCE Elevai Labs Inc.
Share this article